Dr. Reddy's Laboratories has launched Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) Single-dose Vial, a therapeutic equivalent generic version of Hemabate injection, 250 mcg/mL, approved by the US Food and Drug Administration (USFDA).
The Hemabate injection, 250 mcg/mL brand had US sales of approximately $55 million MAT for the most recent twelve months ending in April 2019 according to IQVIA Health.
Dr. Reddy's Carboprost Tromethamine Injection USP, 250 mcg/mL (1mL) contains carboprost tromethamine equivalent to 250 mcg of carboprost.
Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1529.50 |
Dr. Reddys Lab | 6292.70 |
Cipla | 1421.00 |
Zydus Lifesciences | 1017.10 |
Lupin | 1673.30 |
View more.. |